Institutional Ownership Neuro Sense Therapeutics Ltd. (NRSN)
This table provides information about the institutional ownership of Neuro Sense Therapeutics Ltd. (NRSN). We have compiled data on the 12 institutions that hold shares in the stock, with a total of 181,343 shares, which have been reported (via 13F filing form) to have a value of $228,000.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
50,501
shares
|
$63,631
0.0% of portfolio
|
Q1 2025
Reduced 50.77%
|
|
|
Squarepoint Ops LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
49,925
shares
|
$62,905
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Meitav Dash Investments LTD
|
Jul 23, 2025 Q2 2025 |
40,000
shares
|
$50,400
0.0% of portfolio
|
Q2 2024
Reduced 20.0%
|
|
|
Commonwealth Equity Services, LLC
|
Aug 06, 2025 Q2 2025 |
21,080
shares
|
$26,560
0.0% of portfolio
|
Q2 2025
Added 22.2%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
15,870
shares
|
$19,996
0.0% of portfolio
|
Q4 2024
Added 32.66%
|
|
|
Two Sigma Securities, LLC
New York, NY |
May 15, 2025 Q1 2025 |
14,705
shares
|
$18,528
0.0% of portfolio
|
Q1 2025
Reduced 2.08%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
11,828
shares
|
$14,903
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Jones Financial Companies Lllp
|
Aug 13, 2025 Q2 2025 |
10,919
shares
|
$13,757
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Hurley Capital, LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
6,530
shares
|
$8,227
0.01% of portfolio
|
Q2 2025
Reduced 25.03%
|
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Aug 07, 2025 Q2 2025 |
4,455
shares
|
$5,613
0.0% of portfolio
|
Q2 2025
Added 2445.71%
|
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,611
shares
|
$2,029
0.0% of portfolio
|
Q2 2025
Reduced 29.19%
|
|
|
Cwm, LLC
|
Jul 25, 2025 Q2 2025 |
1,000
shares
|
$1,260
0.0% of portfolio
|
Q3 2022
New holding
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|